Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
Ripple is the UK's first-ever clean energy ownership platform. The company aims to enable households and businesses to own new wind farms and solar parks and have the electricity they generate supplied to their home or business premises via the grid. It endeavours to become a segment leader in the $11 trillion global wind and solar market. Ripple has overseen £1 million+ transactions on its platform to date. It has featured in publications like The Times, CNBC, Independent, Business Green, and This Is Money. It has also garnered 5300+ pre-registered customers. The company will use 40% of the investment for marketing purposes, 40% for projects and business overheads, 10% for Non-UK projects, and 10% for website and application development.
days to go:
Expired
investment:
£442,282
Loowatt is delivering safe sanitation and generating energy from waste for sustainable business growth. Loowatt argues that poor sanitation leads to more than £150 billion being lost every year due to health care costs, decreased income and productivity. It aims to change this with its patented toilet. The toilet's waterless flush seals waste hygienically away and is the starting point for Loowatt's unique closed-loop processing system. Loowatt works closely with the local utility partners and ensures that waste is safely collected, treated, and transformed into biogas to generate electricity and heat with nutrients captured for organic fertiliser production. Loowatt has processed 555 tonnes of waste and served more than 250,000 people. The company will use the investment to scale-up manufacturing, complete development of the Loowatt Pro data transmission system, and develop an aftersales monetisation strategy for large international contracts, starting with the City of Manila.
days to go:
Expired
investment:
£1,101,180
Solivus is a solar technology company that aims to enable mega-buildings, homes and communities to lower their carbon footprint and generate local green energy through the company's proprietary solar solutions. Its patent-pending innovation, Solivus Arc, utilises thin-film solar technology to power homes and electric vehicles. The company asserts that Solivus Arc provides an alternative to rooftop solar and has incredible low-carbon credentials. Solivus aims to also enter the commercial and agricultural markets with its products. It will use 50% of the investment in product development and R&D, 40% in growing its team, and 10% towards legal and marketing costs.
days to go:
Expired
investment:
£1,619,048
TV.FIT is a streaming service and app that allows its users to access 100 hours of health & wellbeing content from global fitness experts & celebrities. Its subscription service is accessible in 66 countries across 6 continents. The platform aims to cater to all aspects of fitness, from mental health support for those who have yet to start to improve their fitness to creating content for those who are already working on their fitness regime. Its programs are created by some of the world’s most well-known fitness figures including George St-Pierre, Caroline Pearce, Gemma Atkinson, and Pierre Pozzuto. The platform has a global multimedia reach of over 8 million followers via partners such as TruFusion and CoolEvents, with another 6 million+ prospective users in the pipeline. TV.FIT also disseminates NHS-recommended mental-health-focused content on its platform. With the funds received, the platform aims to invest 31% of it in marketing, 28% in international content development, 22% in capital reserves, 18% in content production, and 1% towards repayment of debt.
days to go:
Expired
investment:
£2,208,212
MysteryVibe creates doctor-recommended sexual health devices. The company combines research and engineering by onboarding leading doctors to design devices that address major sexual health issues such as erectile dysfunction, dryness and pain during intercourse. MysteryVibe has changed over 50,000 lives in 65 countries, witnessed $1 million worth of direct sales in 2020, and became the first sexual health startup to be featured on a BBC documentary. The company has received 20+ international awards including, the coveted Design Week Awards where its product, 'Crescendo', beat the Apple Watch. MysteryVibe has featured in media entities like Men's Health, Women's Health, The Daily Dot, and Forbes, to name a few. The company will use 25% of the investment to expand and scale its digital marketing campaign, 25% to launch two new products, 25% to expand its team, and 25% on building its inventory.
days to go:
Expired
investment:
£498,020
